Humankind Investments LLC
Filing Date
Global Rank
#5,259
/ 8,603
▼ 275
· as of Mar 2026
Top Industry
Software - Infrastructure
35.9%
3Y Alpha vs SPY
-2.7%
Period ended 3 months ago
Filed May 15, 2026 · 55d
22 quarters · since Dec 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+64.9%
SPY
+76.5%
Annualised alpha
-2.7%
Max drawdown
−16.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
13 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
24.0%
−11.8 pts
Top 5
75.1%
−17.1 pts
Top 10
96.9%
−3.1 pts
HHI
1,384
Diversified−947
Portfolio Trend
22 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 47.8% | $58,447,563 |
| Technology | 39.3% | $47,990,996 |
| Healthcare | 12.9% | $15,717,942 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| MSFT | Microsoft Corp | +25,300 | 51,100 | $18,915,687 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IBIT | iShares Bitcoin Trust ETF | 232,000 | $8,913,440 | |
| BMY | Bristol Myers Squibb Co | 100,000 | $6,065,000 | |
| PFE | Pfizer Inc | 211,000 | $5,924,880 | |
| SNPS | Synopsys Inc | 10,000 | $3,964,800 | |
| APGE | Apogee Therapeutics, Inc. | 17,500 | $1,472,975 | |
| EXEL | Exelixis, Inc. | 26,500 | $1,136,585 | |
| BMRN | Biomarin Pharmaceutical Inc | 19,800 | $1,118,502 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| GLD | Spdr Gold Trust | 40,000 | $15,852,400 | |
| No positions match the current search. | ||||
13 positions ·
$122,156,501 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
Reduced | 50,700 | $29,263,026 | 23.96% | |
| SPY |
Spdr S&P 500 ETF Trust
|
Reduced | 31,170 | $20,271,097 | 16.59% | |
| MSFT |
Microsoft Corp
Technology
|
Added | 51,100 | $18,915,687 | 15.48% | |
| AAPL |
Apple Inc.
Technology
|
Held | 56,800 | $14,415,272 | 11.80% | |
| IBIT |
iShares Bitcoin Trust ETF
|
NEW | 232,000 | $8,913,440 | 7.30% | |
| CSCO |
Cisco Systems, Inc.
Technology
|
Held | 83,900 | $6,509,801 | 5.33% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 100,000 | $6,065,000 | 4.96% | |
| PFE |
Pfizer Inc
Healthcare
|
NEW | 211,000 | $5,924,880 | 4.85% | |
| SONY |
Sony Group Corp
Technology
|
Held | 202,195 | $4,185,436 | 3.43% | |
| SNPS |
Synopsys Inc
Technology
|
NEW | 10,000 | $3,964,800 | 3.25% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
NEW | 17,500 | $1,472,975 | 1.21% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
NEW | 26,500 | $1,136,585 | 0.93% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
NEW | 19,800 | $1,118,502 | 0.92% |